Radiation and contrast-free characterization of an unexpected mass during pregnancy.

the elderly has improved: Ontario prescribing trends, 1994–2002. Hypertension 2005;45:1113–1118. 19. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097–1102. 20. Leenen FHH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Lum-Kwong MM, Fodor G. Results of the Ontario Survey on the prevalence and control of hypertension. Can Med Assoc J 2008;178:1441–1449. 21. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008;52:818–827. 22. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007;167:141–147. 23. Campbell NRC, Brant R, Johansen H, Walker R, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009;53:128–134. 24. Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Can J Cardiol 2003;19:1359–1366. 25. Lenfant C. Reflections on Hypertension Control Rates. A Message from the Director of the National Heart, Lung, and Blood Institute. Arch Intern Med 2002;162:131–132.